
Asia Pacific Gene Expression Market Report and Forecast 2024-2032
Description
Asia Pacific Gene Expression Market Report and Forecast 2024-2032
Asia Pacific Gene Expression Market Report and Forecast 2024-2032
Asia Pacific Gene Expression Market Outlook
The global gene expression market size was valued at USD 13.3 billion in 2023, with Asia Pacific holding a significant market share. It is driven by the growing demand for personalized medicine in the region. The market is expected to grow at a CAGR of 12.7% during the forecast period of 2024-2032, with the values likely attain USD 32.4 billion by 2032.
Key Takeaways
- Growth in cancer incidence along with other chronic diseases wherein gene expression may contribute as an effective treatment alternative is a significant factor boosting the market growth.
- The Asia Pacific gene expression market share is propelled by increasing adoption of innovative technologies. Milner Therapeutics Institute (MTI) at the University of Cambridge and AstraZeneca partnered in November 2023, to understand the genomic relationship with chronic diseases by using technologies like CRISPR.
- The market value is driven by increasing incidence of collaborations and acquisitions to develop and implement best resources in the region. In May 2023, Pfizer, and Thermo Fisher Scientific Inc., collaborated to provide local access to NGS test for lung and breast cancer patients in over 30 countries.
Gene expression is a process by which information encoded in a gene is used in the synthesis of a functional gene product which enables to produce proteins or end products. It involves different processes such as gene transcription, translation, post-translational modification of protein and RNA splicing among others. Asia Pacific is accountable for 50% of the overall new cancer cases worldwide. The cancer associated mortality rate is likely to increase by 36% in the coming years. With a deeper understanding of human physiology and rising burden of chronic illnesses like cancer and other rare diseases, gene expression finds its application in multiple medical domains. Consequently, the Asia Pacific gene expression market demand has witness growth in recent years.
In May 2023, Thermo Fisher Scientific Inc. and Pfizer entered into a collaboration agreement with an aim to enhance the local access to next-generation sequencing (NGS) tests for breast and lung cancer patients across several countries. The initiative was specifically aimed at regions where advanced genomic testing had been unavailable or limited. The access to NGS testing provides quicker gene analysis, enabling healthcare providers to efficiently choose the appropriate treatments for the individual patient. The Asia Pacific gene expression market growth is fuelled by such initiatives.
Increasing incorporation of cutting-edge technologies to yield most effective results in disease management and treatment is one of the major market trends. In November 2023, AstraZeneca and University of Cambridge expanded functional genomics partnership. At the university, scientists engaged in the utilization of advanced CRISPR technology to understand the genetic mechanisms better. This can lead to the development of effective treatment for multiple diseases including severe respiratory, cardiovascular, and metabolic diseases.
One of the significant Asia Pacific gene expression market trends include increased healthcare expenditure and investments to meet the rising demand for molecular diagnostics and personalized medicine. The expansion of health and pharmaceutical industry in emerging economies such as India, South Korea and Singapore has led to a greater demand for gene expression profiling. This can be attributed to increased incidence of drug discovery and development processes, which includes target identification, biomarker discovery, and preclinical studies.
Asia Pacific Gene Expression Market Segmentation
Market Breakup by Process
- Sample Collection
- Purification
- cDNA synthesis and Conversion
- PCR Analysis
- Data Analysis and Interpretation
- Clinical Diagnostics
- Drug Discovery and Development
- Research Activities
- Other Applications
- RNA Expression
- Promoter Analysis
- Protein Expression and Posttranslational Modification Analysis
- Consumables
- Instruments
- Service
- Pharmaceutical and Biotechnology Companies
- Diagnostic Laboratories
- Academic Research Centres
- Japan
- India
- ASEAN
- Australia
- Others
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- F. Hoffmann-La Roche Ltd
- QIAGEN
- Oxford Gene Technology (OGT) Group
- Eurofins Scientific
- LGC Limited
- Promega Corporation
- Takara Bio Inc.
- PacBio
- Smith & Nephew plc
- Abbott
FAQs
- What is the Asia Pacific gene expression market forecast outlook for 2024-2032?
- What are the major factors aiding the Asia Pacific gene expression market demand?
- What are the major factors aiding the Asia Pacific gene expression market trends?
- What is the market segmentation based on process?
- What is the market breakup by application?
- What is the market segmentation based on technique?
- What are the major end users of gene expression market?
- What is the market segmentation by countries?
- Who are the key players involved in the Asia Pacific gene expression market?
Meta description
The Asia Pacific gene expression market size is impacted by the increasing demand in the global market, which was valued at USD 13.3 billion in 2023 and it is anticipated to grow at a CAGR of 10.4% during the forecast period of 2024-2032.
*Please Note:* The report will take 7 business days to complete, after order confirmation.
Table of Contents
140 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Asia Pacific Gene Expression Market Overview
- 3.1 Asia Pacific Gene Expression Market Historical Value (2017-2023)
- 3.2 Asia Pacific Gene Expression Market Forecast Value (2024-2032)
- 4 Asia Pacific Gene Expression Market Landscape*
- 4.1 Asia Pacific Gene Expression: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Asia Pacific Gene Expression: Product Landscape
- 4.2.1 Analysis by Process
- 4.2.2 Analysis by Application
- 5 Asia Pacific Gene Expression Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.2.1 Strengths
- 5.2.2 Weaknesses
- 5.2.3 Opportunities
- 5.2.4 Threats
- 5.3 Porter’s Five Forces Model
- 5.3.1 Bargaining Power of Suppliers
- 5.3.2 Bargaining Power of Buyers
- 5.3.3 Threat of New Entrants
- 5.3.4 Threat of Substitutes
- 5.3.5 Degree of Rivalry
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Asia Pacific Gene Expression Market Segmentation (2017-2032)
- 6.1 Asia Pacific Gene Expression Market (2017-2032) by Process
- 6.1.1 Market Overview
- 6.1.2 Sample Collection
- 6.1.3 Purification
- 6.1.4 cDNA Synthesis & Conversion
- 6.1.5 PCR Analysis
- 6.1.6 Data Analysis & Interpretation
- 6.2 Asia Pacific Gene Expression Market (2017-2032) by Application
- 6.2.1 Market Overview
- 6.2.2 Clinical Diagnostics
- 6.2.3 Drug Discovery & Development
- 6.2.4 Research Activities
- 6.2.5 Other Applications
- 6.3 Asia Pacific Gene Expression Market (2017-2032) by Technique
- 6.3.1 Market Overview
- 6.3.2 RNA Expression
- 6.3.3 Promoter Analysis
- 6.3.4 Protein Expression & Posttranslational Modification Analysis
- 6.4 Asia Pacific Gene Expression Market (2017-2032) by Product
- 6.4.1 Market Overview
- 6.4.2 Consumables
- 6.4.3 Instruments
- 6.4.4 Services
- 6.5 Asia Pacific Gene Expression Market (2017-2032) by End User
- 6.5.1 Market Overview
- 6.5.2 Pharmaceutical and Biotechnology Companies
- 6.5.3 Diagnostic Laboratories
- 6.5.4 Academic Research Centers
- 6.6 Asia Pacific Gene Expression Market (2017-2032) by Country
- 6.6.1 Market Overview
- 6.6.2 Japan
- 6.6.3 India
- 6.6.4 ASEAN
- 6.6.5 Australia
- 6.6.6 Others
- 7 Japan Gene Expression Market (2017-2032)
- 7.1 Japan Gene Expression Market (2017-2032) by Process
- 7.1.1 Market Overview
- 7.1.2 Sample Collection
- 7.1.3 Purification
- 7.1.4 cDNA Synthesis & Conversion
- 7.1.5 PCR Analysis
- 7.1.6 Data Analysis & Interpretation
- 7.2 Japan Gene Expression Market (2017-2032) by Application
- 7.2.1 Market Overview
- 7.2.2 Clinical Diagnostics
- 7.2.3 Drug Discovery & Development
- 7.2.4 Research Activities
- 7.2.5 Other Applications
- 7.3 Japan Gene Expression Market (2017-2032) by Technique
- 7.3.1 Market Overview
- 7.3.2 RNA Expression
- 7.3.3 Promoter Analysis
- 7.3.4 Protein Expression & Posttranslational Modification Analysis
- 7.4 Japan Gene Expression Market (2017-2032) by Product
- 7.4.1 Market Overview
- 7.4.2 Consumables
- 7.4.3 Instruments
- 7.4.4 Services
- 7.5 Japan Gene Expression Market (2017-2032) by End User
- 7.5.1 Market Overview
- 7.5.2 Pharmaceutical and Biotechnology Companies
- 7.5.3 Diagnostic Laboratories
- 7.5.4 Academic Research Centers
- 8 India Gene Expression Market (2017-2032)
- 8.1 India Gene Expression Market (2017-2032) by Process
- 8.1.1 Market Overview
- 8.1.2 Sample Collection
- 8.1.3 Purification
- 8.1.4 cDNA Synthesis & Conversion
- 8.1.5 PCR Analysis
- 8.1.6 Data Analysis & Interpretation
- 8.2 India Gene Expression Market (2017-2032) by Application
- 8.2.1 Market Overview
- 8.2.2 Clinical Diagnostics
- 8.2.3 Drug Discovery & Development
- 8.2.4 Research Activities
- 8.2.5 Other Applications
- 8.3 India Gene Expression Market (2017-2032) by Technique
- 8.3.1 Market Overview
- 8.3.2 RNA Expression
- 8.3.3 Promoter Analysis
- 8.3.4 Protein Expression & Posttranslational Modification Analysis
- 8.4 India Gene Expression Market (2017-2032) by Product
- 8.4.1 Market Overview
- 8.4.2 Consumables
- 8.4.3 Instruments
- 8.4.4 Services
- 8.5 India Gene Expression Market (2017-2032) by End User
- 8.5.1 Market Overview
- 8.5.2 Pharmaceutical and Biotechnology Companies
- 8.5.3 Diagnostic Laboratories
- 8.5.4 Academic Research Centers
- 9 ASEAN Gene Expression Market (2017-2032)
- 9.1 ASEAN Gene Expression Market (2017-2032) by Process
- 9.1.1 Market Overview
- 9.1.2 Sample Collection
- 9.1.3 Purification
- 9.1.4 cDNA synthesis & conversion
- 9.1.5 PCR Analysis
- 9.1.6 Data analysis & interpretation
- 9.2 ASEAN Gene Expression Market (2017-2032) by Application
- 9.2.1 Market Overview
- 9.2.2 Clinical Diagnostics
- 9.2.3 Drug Discovery & Development
- 9.2.4 Research Activities
- 9.2.5 Other Applications
- 9.3 ASEAN Gene Expression Market (2017-2032) by Technique
- 9.3.1 Market Overview
- 9.3.2 RNA Expression
- 9.3.3 Promoter Analysis
- 9.3.4 Protein Expression & Posttranslational Modification Analysis
- 9.4 ASEAN Gene Expression Market (2017-2032) by Product
- 9.4.1 Market Overview
- 9.4.2 Consumables
- 9.4.3 Instruments
- 9.4.4 Services
- 9.5 ASEAN Gene Expression Market (2017-2032) by End User
- 9.5.1 Market Overview
- 9.5.2 Pharmaceutical and Biotechnology Companies
- 9.5.3 Diagnostic Laboratories
- 9.5.4 Academic Research Centers
- 10 Australia Gene Expression Market (2017-2032)
- 10.1 Australia Gene Expression Market (2017-2032) by Process
- 10.1.1 Market Overview
- 10.1.2 Sample Collection
- 10.1.3 Purification
- 10.1.4 cDNA Synthesis & Conversion
- 10.1.5 PCR Analysis
- 10.1.6 Data Analysis & Interpretation
- 10.2 Australia Gene Expression Market (2017-2032) by Application
- 10.2.1 Market Overview
- 10.2.2 Clinical Diagnostics
- 10.2.3 Drug Discovery & Development
- 10.2.4 Research Activities
- 10.2.5 Other Applications
- 10.3 Australia Gene Expression Market (2017-2032) by Technique
- 10.3.1 Market Overview
- 10.3.2 RNA Expression
- 10.3.3 Promoter Analysis
- 10.3.4 Protein Expression & Posttranslational Modification Analysis
- 10.4 Australia Gene Expression Market (2017-2032) by Product
- 10.4.1 Market Overview
- 10.4.2 Consumables
- 10.4.3 Instruments
- 10.4.4 Services
- 10.5 Australia Gene Expression Market (2017-2032) by End User
- 10.5.1 Market Overview
- 10.5.2 Pharmaceutical and Biotechnology companies
- 10.5.3 Diagnostic Laboratories
- 10.5.4 Academic Research Centers
- 11 Regulatory Framework
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication Year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by Year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding and Investment Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Supplier Landscape
- 16.1 Market Share by Top 5 Companies
- 16.2 F. Hoffmann-La Roche Ltd
- 16.2.1 Financial Analysis
- 16.2.2 Product Portfolio
- 16.2.3 Demographic Reach and Achievements
- 16.2.4 Mergers and Acquisitions
- 16.2.5 Certifications
- 16.3 QIAGEN
- 16.3.1 Financial Analysis
- 16.3.2 Product Portfolio
- 16.3.3 Demographic Reach and Achievements
- 16.3.4 Mergers and Acquisitions
- 16.3.5 Certifications
- 16.4 Oxford Gene Technology (OGT) Group
- 16.4.1 Financial Analysis
- 16.4.2 Product Portfolio
- 16.4.3 Demographic Reach and Achievements
- 16.4.4 Mergers and Acquisitions
- 16.4.5 Certifications
- 16.5 Eurofins Scientific
- 16.5.1 Financial Analysis
- 16.5.2 Product Portfolio
- 16.5.3 Demographic Reach and Achievements
- 16.5.4 Mergers and Acquisitions
- 16.5.5 Certifications
- 16.6 LGC Limited
- 16.6.1 Financial Analysis
- 16.6.2 Product Portfolio
- 16.6.3 Demographic Reach and Achievements
- 16.6.4 Mergers and Acquisitions
- 16.6.5 Certifications
- 16.7 Promega Corporation
- 16.7.1 Financial Analysis
- 16.7.2 Product Portfolio
- 16.7.3 Demographic Reach and Achievements
- 16.7.4 Mergers and Acquisitions
- 16.7.5 Certifications
- 16.8 Takara Bio Inc.
- 16.8.1 Financial Analysis
- 16.8.2 Product Portfolio
- 16.8.3 Demographic Reach and Achievements
- 16.8.4 Mergers and Acquisitions
- 16.8.5 Certifications
- 16.9 PacBio
- 16.9.1 Financial Analysis
- 16.9.2 Product Portfolio
- 16.9.3 Demographic Reach and Achievements
- 16.9.4 Mergers and Acquisitions
- 16.9.5 Certifications
- 16.10 Smith & Nephew plc
- 16.10.1 Financial Analysis
- 16.10.2 Product Portfolio
- 16.10.3 Demographic
- 16.10.4 Mergers and Acquisitions
- 16.10.5 Certifications
- 16.11 Abbott
- 16.11.1 Financial Analysis
- 16.11.2 Product Portfolio
- 16.11.3 Demographic Reach and Achievements
- 16.11.4 Mergers and Acquisitions
- 16.11.5 Certifications
- 17 Asia Pacific Gene Expression Market – Distribution Model (Additional Insight)
- 17.1 Overview
- 17.2 Potential Distributors
- 17.3 Key Parameters for Distribution Partner Assessment
- 18 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 19 Company Competitiveness Analysis (Additional Insight)
- 19.1 Very Small Companies
- 19.2 Small Companies
- 19.3 Mid-Sized Companies
- 19.4 Large Companies
- 19.5 Very Large Companies
- 20 Payment Methods (Additional Insight)
- 20.1 Government Funded
- 20.2 Private Insurance
- 20.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.